AMPIO PHARMACEUTICALS INC's ticker is and the CUSIP is 03209T959. A total of 3 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -80.0% | 14,600 | -52.3% | 0.00% | – |
| Q2 2022 | $5,000 | -66.7% | 30,600 | -2.9% | 0.00% | – |
| Q1 2022 | $15,000 | -28.6% | 31,500 | -13.0% | 0.00% | – |
| Q4 2021 | $21,000 | +200.0% | 36,200 | +805.0% | 0.00% | – |
| Q3 2021 | $7,000 | -88.7% | 4,000 | -89.2% | 0.00% | – |
| Q2 2021 | $62,000 | -21.5% | 37,200 | -20.7% | 0.00% | – |
| Q1 2021 | $79,000 | -74.9% | 46,900 | -76.3% | 0.00% | -100.0% |
| Q4 2020 | $315,000 | +916.1% | 197,900 | +501.5% | 0.00% | – |
| Q3 2020 | $31,000 | +106.7% | 32,900 | +37.7% | 0.00% | – |
| Q2 2020 | $15,000 | +87.5% | 23,900 | +20.7% | 0.00% | – |
| Q1 2020 | $8,000 | -20.0% | 19,800 | +11.9% | 0.00% | – |
| Q4 2019 | $10,000 | +66.7% | 17,700 | +46.3% | 0.00% | – |
| Q3 2019 | $6,000 | -57.1% | 12,100 | -67.6% | 0.00% | – |
| Q2 2019 | $14,000 | +366.7% | 37,300 | +677.1% | 0.00% | – |
| Q1 2019 | $3,000 | -25.0% | 4,800 | -55.1% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 10,700 | -3.6% | 0.00% | – |
| Q3 2018 | $6,000 | -87.0% | 11,100 | -46.4% | 0.00% | – |
| Q2 2018 | $46,000 | -68.7% | 20,700 | -52.1% | 0.00% | -100.0% |
| Q1 2018 | $147,000 | +6.5% | 43,200 | +27.1% | 0.00% | 0.0% |
| Q4 2017 | $138,000 | +500.0% | 34,000 | -10.5% | 0.00% | – |
| Q3 2017 | $23,000 | +1050.0% | 38,000 | +1087.5% | 0.00% | – |
| Q2 2017 | $2,000 | -33.3% | 3,200 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | -96.7% | 3,200 | -96.9% | 0.00% | -100.0% |
| Q4 2016 | $92,000 | +21.1% | 101,700 | -1.2% | 0.00% | 0.0% |
| Q3 2016 | $76,000 | -79.5% | 102,900 | -64.1% | 0.00% | -75.0% |
| Q2 2016 | $370,000 | +43.4% | 286,600 | +150.3% | 0.00% | 0.0% |
| Q1 2016 | $258,000 | +54.5% | 114,500 | +140.0% | 0.00% | +100.0% |
| Q4 2015 | $167,000 | +288.4% | 47,700 | +218.0% | 0.00% | +100.0% |
| Q3 2015 | $43,000 | -55.7% | 15,000 | -63.2% | 0.00% | 0.0% |
| Q2 2015 | $97,000 | -90.0% | 40,800 | -68.5% | 0.00% | -93.3% |
| Q1 2015 | $974,000 | +73.9% | 129,400 | -20.7% | 0.02% | +87.5% |
| Q4 2014 | $560,000 | -25.4% | 163,200 | -23.3% | 0.01% | -33.3% |
| Q3 2014 | $751,000 | +40.6% | 212,800 | +233.0% | 0.01% | +50.0% |
| Q2 2014 | $534,000 | -40.9% | 63,900 | -55.1% | 0.01% | -46.7% |
| Q1 2014 | $904,000 | +2.0% | 142,400 | +14.7% | 0.02% | +15.4% |
| Q4 2013 | $886,000 | +96.9% | 124,200 | +107.0% | 0.01% | +44.4% |
| Q3 2013 | $450,000 | +65.4% | 60,000 | +27.1% | 0.01% | +28.6% |
| Q2 2013 | $272,000 | – | 47,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,408 | $497,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 212,800 | $751,000 | 0.01% |
| Citadel Advisors | 117,000 | $413,000 | 0.00% |